Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats

Journal of Hepatology

Volumn 33, Issue 5, 2000, Pages 733-737

  Gottardi, Andrea De ^a   Shaw, Sidney ^b   Sagesser, Hans ^a   Reichen, Jurg ^a,b  

^a Departments of Clinical Pharmacology   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endothelin receptor antagonists; Portal hypertension; Splanchnic circulation

Indexed keywords

(2ALPHA,3BETA,4ALPHA) 4 (1,3 BENZODIOXOL 5 YL) 1 [2 (2,6 DIETHYLPHENYL)AMINO] 2 OXOETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; A 182086; ATRASENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SPLANCHNIC BLOOD FLOW; VEIN LIGATION;

EID: 0033763833     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80303-7     Document Type: Article

References (23)

1. Cloning and expression of a cDNA encoding an endothelin receptor
2. Endothelin ET(A) and ET(B) receptors cause vasoconstriction of human resistance and capacitance vessels in vivo
3. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells
4. Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells: Receptor coupling to nitric oxyde synthase
5. Liver function and pharmacological considerations in the pathogenesis and treatment of portal hypertension
6. Vascular endothelin-1 increases selectively in the prestenotic area in partial portal vein ligation in the rat
7. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1
8. Distribution of endothelin-1-receptor subtypes in rat portal vein
9. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: Role in splanchnic hemodynamics
10. Potent constrictor actions of endothelin-1, -2 and -3 in rat isolated portal vein
11. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: Localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction
12. Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver
13. Effect of two models of portal hypertension on splanchnic organ blood flow in the rat
14. Splancnic hemodynamics in portal hypertensive rats: Measurement with γ-labeled microspheres
15. Changes in splanchnic blood flow in portal hypertensive rats
16. Angiotensin II increases vascular and renal endothelin 1 and functional endothelin converting enzyme activity in vivo: Role of ET(A) receptors for endothelin regulation
17. The evolution of changes in quantitative liver function tests in a rat model of cirrhosis: Correlation with morphometric measurement of hepatocyte mass
18. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats
19. The effect of endothelin and its antagonist bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver
20. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats
21. Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effects
22. Vasoactive effect of endothelin-1 on rat liver in vivo
23. ET-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action